{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:37:34Z","timestamp":1787341054360,"version":"build-2736575974"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/35\/O\/NZ2\/03761"],"award-info":[{"award-number":["2019\/35\/O\/NZ2\/03761"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11864-026-01410-3","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:18:28Z","timestamp":1787293108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimising Clinical Outcomes Following R1 Resection in Soft Tissue Sarcoma: An Evidence-Based Approach"],"prefix":"10.1007","volume":"27","author":[{"given":"Piotr","family":"Remiszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Rosi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Sukiennik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Chmiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szumera-Cie\u0107kiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"1410_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11912-024-01630-6","volume":"27","author":"P Remiszewski","year":"2025","unstructured":"Remiszewski P, Filipek K, Pisklak A, et al. Neoadjuvant or adjuvant chemotherapy in soft-tissue sarcoma? Curr Oncol Rep. 2025;27:491\u2013515. https:\/\/doi.org\/10.1007\/s11912-024-01630-6","journal-title":"Curr Oncol Rep"},{"key":"1410_CR2","doi-asserted-by":"crossref","unstructured":"Chmiel P, Rutkowski P, Spa\u0142ek M, et al (2024) What is the optimal treatment strategy after sarcoma R2 Surgery? Curr Treat Options Oncol. 25:798\u2013812.","DOI":"10.1007\/s11864-024-01218-z"},{"key":"1410_CR3","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.L.01149","author":"BK Potter","year":"2013","unstructured":"Potter BK, Hwang PF, Forsberg JA, et al. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes. J Bone Joint Surg Am. 2013. https:\/\/doi.org\/10.2106\/JBJS.L.01149.","journal-title":"J Bone Joint Surg Am"},{"key":"1410_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.6941","author":"KR Gundle","year":"2018","unstructured":"Gundle KR, Kafchinski L, Gupta S, et al. Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection. J Clin Oncol. 2018. https:\/\/doi.org\/10.1200\/JCO.2017.74.6941.","journal-title":"J Clin Oncol"},{"key":"1410_CR5","doi-asserted-by":"crossref","unstructured":"Spa\u0142ek MJ, Kose\u0142a-Paterczyk H, Borkowska A, et al. Combined preoperative hypofractionated RT With doxorubicin-ifosfamide chemotherapy in marginally resectable soft tissue sarcomas: results of a phase 2 clinical Trial. Int J Radiat Oncol Biol Phys. 2021;110:1053\u20131063.","DOI":"10.1016\/j.ijrobp.2021.02.019"},{"key":"1410_CR6","doi-asserted-by":"publisher","unstructured":"Blay JY, Penel N, Valentin T, et al. Improved nationwide survival of sarcoma patients with a network of reference centers. Annals of oncology : official journal of the European Society for Medical Oncology. 2024;35. https:\/\/doi.org\/10.1016\/j.annonc.2024.01.001.","DOI":"10.1016\/j.annonc.2024.01.001"},{"key":"1410_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25052","author":"T Abarca","year":"2018","unstructured":"Abarca T, Gao Y, Monga V, et al. Improved survival for extremity soft tissue sarcoma treated in high-volume facilities. J Surg Oncol. 2018. https:\/\/doi.org\/10.1002\/jso.25052.","journal-title":"J Surg Oncol"},{"key":"1410_CR8","doi-asserted-by":"publisher","unstructured":"Lazarides AL, Kerr DL, Nussbaum DP, et al. Soft Tissue sarcoma of the extremities: what is the value of treating at high-volume centers? Clinical orthopaedics and related research.\u00a02019:477. https:\/\/doi.org\/10.1097\/01.blo.0000533623.60399.1b.","DOI":"10.1097\/01.blo.0000533623.60399.1b"},{"key":"1410_CR9","doi-asserted-by":"publisher","unstructured":"Martin-Broto J, Hindi N, Cruz J, et al. Relevance of reference centers in sarcoma care and quality item evaluation: results from the prospective registry of the spanish group for research in sarcoma (GEIS). The oncologist. 2019:24. https:\/\/doi.org\/10.1634\/theoncologist.2018-0121.","DOI":"10.1634\/theoncologist.2018-0121"},{"key":"1410_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.06.003","author":"AM Hong","year":"2023","unstructured":"Hong AM, Sundaram A, Perianayagam G, et al. Surgery at specialised sarcoma centres improves patient outcomes - a systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party. Eur J Surg Oncol. 2023. https:\/\/doi.org\/10.1016\/j.ejso.2023.06.003.","journal-title":"Eur J Surg Oncol"},{"key":"1410_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.11.123","author":"AS Melis","year":"2022","unstructured":"Melis AS, Vos M, Schuurman MS, et al. Incidence of unplanned excisions of soft tissue sarcomas in the Netherlands: a population-based study. Eur J Surg Oncol. 2022. https:\/\/doi.org\/10.1016\/j.ejso.2021.11.123.","journal-title":"Eur J Surg Oncol"},{"key":"1410_CR12","doi-asserted-by":"publisher","unstructured":"Sch\u00e4rer M, H\u00f6sli P, Heesen P, et al. Integrated care in specialized networks: leveraging early referrals to reduce local recurrence in soft tissue sarcoma. Cancers.\u00a02024:16. https:\/\/doi.org\/10.3390\/cancers16213616.","DOI":"10.3390\/cancers16213616"},{"key":"1410_CR13","doi-asserted-by":"publisher","unstructured":"Mendelez-Fernandez AP, Garcia-Ortega DY, Carlo-Sanchezs CH, et al. Do unplanned resections in soft tissue sarcomas of the extremities have an adverse impact on the prognosis? Experience of a Latin-American sarcoma reference center. Surgical oncology. 2025:59. https:\/\/doi.org\/10.1016\/j.suronc.2025.102210","DOI":"10.1016\/j.suronc.2025.102210"},{"key":"1410_CR14","doi-asserted-by":"publisher","unstructured":"Nydegger KN, Obergfell TTAF, Heesen P, et al. Planned and unplanned sarcoma resections: comparative analysis of local recurrence, metastasis, and mortality. Cancers.\u00a02024:16 https:\/\/doi.org\/10.3390\/cancers16193408","DOI":"10.3390\/cancers16193408"},{"key":"1410_CR15","doi-asserted-by":"publisher","unstructured":"Jahn J, Dean KK, Travis LM, et al. Effect of timing of first consultation with a sarcoma specialist following unplanned excision: oncologic outcomes of patients with soft-tissue sarcomas. The Journal of bone and joint surgery American volume. 2026. https:\/\/doi.org\/10.2106\/JBJS.25.01239.","DOI":"10.2106\/JBJS.25.01239"},{"key":"1410_CR16","doi-asserted-by":"publisher","unstructured":"Fujiwara T, Evans S, Stevenson J, et al. Impact of the national sarcoma guidelines on the prevalence and outcome of inadvertent excisions of soft tissue sarcomas: An observational study from a UK tertiary referral centre. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2022:48. https:\/\/doi.org\/10.1016\/j.ejso.2021.11.013.","DOI":"10.1016\/j.ejso.2021.11.013"},{"key":"1410_CR17","doi-asserted-by":"crossref","unstructured":"Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021;32:1348\u20131365.","DOI":"10.1016\/j.annonc.2021.07.006"},{"key":"1410_CR18","unstructured":"von Mehren M, Kane JM 3rd, Armstrong SA, et al. NCCN guidelines\u00ae insights: soft tissue sarcoma, version 1.2025. J Natl Compr Canc Netw. 2025;23:498\u2013506."},{"key":"1410_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.12.002","author":"E Andritsch","year":"2017","unstructured":"Andritsch E, Beishon M, Bielack S, et al. ECCO essential requirements for quality cancer care: soft tissue sarcoma in adults and bone sarcoma. A critical review. Crit Rev Oncol Hematol. 2017. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.12.002.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1410_CR20","first-page":"149","volume":"9","author":"H Piotr Rutkowski","year":"2023","unstructured":"Piotr Rutkowski H, Kose\u0142a-Paterczyk K, Kozak I, \u0141ugowska J, Fijuth A, Jeziorski J, Ry\u015b M, Spa\u0142ek A, Borkowska. Micha\u0142 W\u0105grodzki, Tomasz \u015awitaj, Piotr Fonrobert, Urszula Grzesiakowska, Zbigniew I. Nowecki, Mariusz Bidzi\u0144ski, Andrzej Tysarowski, Hanna Tch\u00f3rzewska-Korba, Marcin Zdzienicki. Onkol Prakt Klin Edu. 2023;9:149\u201380. Post\u0119powanie diagnostyczno-terapeutyczne u chorych na mi\u0119saki tkanek mi\u0119kkich u doros\u0142ych - zalecenia ekspert\u00f3w.","journal-title":"Onkol Prakt Klin Edu"},{"key":"1410_CR21","doi-asserted-by":"publisher","unstructured":"Mart\u00edn BJ. Advancing towards better cooperation for better sarcoma prognoses. Oncology.\u00a02018;95:Suppl 1. https:\/\/doi.org\/10.1159\/000494860.","DOI":"10.1159\/000494860"},{"key":"1410_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.04.006","author":"C Benson","year":"2014","unstructured":"Benson C, Judson I. Role of expert centres in the management of sarcomas\u2013a UK perspective. Eur J Cancer. 2014. https:\/\/doi.org\/10.1016\/j.ejca.2014.04.006.","journal-title":"Eur J Cancer"},{"key":"1410_CR23","doi-asserted-by":"publisher","unstructured":"Blay JY, Soibinet P, Penel N, et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Annals of oncology : official journal of the European Society for Medical Oncology. 2017:28. https:\/\/doi.org\/10.1093\/annonc\/mdx484.","DOI":"10.1093\/annonc\/mdx484"},{"key":"1410_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz124","author":"JY Blay","year":"2019","unstructured":"Blay JY, Honor\u00e9 C, Stoeckle E, et al. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann Oncol. 2019. https:\/\/doi.org\/10.1093\/annonc\/mdz124.","journal-title":"Ann Oncol"},{"key":"1410_CR25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s11864-025-01348-y","volume":"26","author":"P Remiszewski","year":"2025","unstructured":"Remiszewski P, Pisklak A, Filipek K, et al. Dermatofibrosarcoma protuberans (DFSP): current treatments and clinical trials. Curr Treat Options Oncol. 2025;26:967\u201389. https:\/\/doi.org\/10.1007\/s11864-025-01348-y","journal-title":"Curr Treat Options Oncol"},{"key":"1410_CR26","doi-asserted-by":"crossref","unstructured":"Swallow CJ, Strauss DC, Bonvalot S, et al. Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic australasian RPS working group. Ann Surg Oncol. 2021;28:7873\u20137888.","DOI":"10.1245\/s10434-021-09654-z"},{"key":"1410_CR27","doi-asserted-by":"publisher","unstructured":"Baudo A, de Angelis M, Siech C, et al. Perioperative RT and survival after surgical treatment of nonmetastatic retroperitoneal sarcoma. J Natl Compr Canc Netw. 2025:23. https:\/\/doi.org\/10.6004\/jnccn.2025.7056.","DOI":"10.6004\/jnccn.2025.7056"},{"key":"1410_CR28","doi-asserted-by":"crossref","unstructured":"Bonvalot S, Gronchi A, Le P\u00e9choux C, et al. Preoperative RT plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020;21:1366\u20131377.","DOI":"10.1016\/S1470-2045(20)30446-0"},{"key":"1410_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(16)00010-3","volume":"17","author":"D Callegaro","year":"2016","unstructured":"Callegaro D, Miceli R, Bonvalot S, et al. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol. 2016;17:671\u201380.","journal-title":"Lancet Oncol"},{"key":"1410_CR30","doi-asserted-by":"crossref","unstructured":"Stillman M, Espat NJ, Kwon S. Validation of updated sarculator nomogram for primary retroperitoneal sarcoma in the United States. Ann Surg Oncol. 2026;33:3606\u20133616.","DOI":"10.1245\/s10434-025-18873-7"},{"key":"1410_CR31","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1245\/s10434-021-11205-5","volume":"29","author":"MH Squires","year":"2022","unstructured":"Squires MH, Ethun CG, Donahue EE, et al. Extremity soft tissue sarcoma: a multi-institutional validation of prognostic nomograms. Ann Surg Oncol. 2022;29:3291\u2013301.","journal-title":"Ann Surg Oncol"},{"key":"1410_CR32","doi-asserted-by":"publisher","unstructured":"Voss RK, Callegaro D, Chiang Y-J, et al. Sarculator is a good model to predict survival in resected extremity and trunk sarcomas in US Patients. Ann Surg Oncol. 2022. https:\/\/doi.org\/10.1245\/s10434-022-11442-2.","DOI":"10.1245\/s10434-022-11442-2"},{"key":"1410_CR33","doi-asserted-by":"publisher","unstructured":"Pasquali S, Palmerini E, Quagliuolo V, et al. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer. 2022:128. https:\/\/doi.org\/10.1002\/cncr.33895.","DOI":"10.1002\/cncr.33895"},{"key":"1410_CR34","doi-asserted-by":"publisher","unstructured":"Wang H, Chen B, Cen Y, Chen J. Evaluation of efficacy of adjuvant rt in well-differentiated liposarcoma patients with positive surgical margins: a population-based study. Journal of oncology 2022. 2022. https:\/\/doi.org\/10.1155\/2022\/5735679.","DOI":"10.1155\/2022\/5735679"},{"key":"1410_CR35","doi-asserted-by":"crossref","unstructured":"Vodanovich DA, Spelman T, May D, et al. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases. ANZ J Surg. 2019;89:1045\u20131050.","DOI":"10.1111\/ans.15348"},{"key":"1410_CR36","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00264-015-2694-x","volume":"39","author":"J Willeumier","year":"2015","unstructured":"Willeumier J, Fiocco M, Nout R, et al. High-grade soft tissue sarcomas of the extremities: surgical margins influence only local recurrence not overall survival. Int Orthop. 2015;39:935\u201341.","journal-title":"Int Orthop"},{"key":"1410_CR37","doi-asserted-by":"publisher","unstructured":"Goertz O, Pieper A, Lohe L von der, et al. The impact of surgical margins and adjuvant RT in patients with undifferentiated pleomorphic sarcomas of the extremities: a single-institutional analysis of 192 patients. Cancers (Basel). 2020:12. https:\/\/doi.org\/10.3390\/cancers12020362.","DOI":"10.3390\/cancers12020362"},{"key":"1410_CR38","doi-asserted-by":"crossref","unstructured":"Iwata S, Araki A, Funatsu H, et al. Optimal surgical margin for infiltrative soft tissue sarcomas: Assessing the efficacy of excising beyond the infiltration. J Surg Oncol.\u00a02018;118:525\u2013531.","DOI":"10.1002\/jso.25165"},{"key":"1410_CR39","doi-asserted-by":"crossref","unstructured":"Dadrass F, Gusho C, Yang F, et al. A clinicopathologic examination of myxofibrosarcoma. Do surgical margins significantly affect local recurrence rates in this infiltrative sarcoma subtype? J Surg Oncol. 2021;123:489\u2013496.","DOI":"10.1002\/jso.26277"},{"key":"1410_CR40","doi-asserted-by":"crossref","unstructured":"Fujiwara T, Sumathi V, Parry M, et al. The role of surgical margin quality in myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Eur J Surg Oncol. 2021;47:1756\u20131762.","DOI":"10.1016\/j.ejso.2020.11.144"},{"key":"1410_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.suronc.2020.08.022","volume":"35","author":"T Fujiwara","year":"2020","unstructured":"Fujiwara T, Kaneuchi Y, Tsuda Y, et al. Low-grade soft-tissue sarcomas: what is an adequate margin for local disease control? Surg Oncol. 2020;35:303\u20138.","journal-title":"Surg Oncol"},{"key":"1410_CR42","doi-asserted-by":"publisher","unstructured":"O\u2019Donnell PW, Griffin AM, Eward WC, et al. The effect of the setting of a positive surgical margin in soft tissue sarcoma. Cancer.\u00a02014:120. https:\/\/doi.org\/10.1002\/cncr.28793.","DOI":"10.1002\/cncr.28793"},{"key":"1410_CR43","doi-asserted-by":"crossref","unstructured":"Kawaguchi N, Matumoto S, Manabe J. New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma, analysed on the basis of 457 surgical cases. J Cancer Res Clin Oncol. 1995;121:555\u2013563.","DOI":"10.1007\/BF01197769"},{"key":"1410_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25522","author":"NP Gannon","year":"2019","unstructured":"Gannon NP, King DM, Ethun CG, et al. The role of radiation therapy and margin width in localized soft-tissue sarcoma: analysis from the US Sarcoma Collaborative. J Surg Oncol. 2019. https:\/\/doi.org\/10.1002\/jso.25522.","journal-title":"J Surg Oncol"},{"key":"1410_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1445-2197.2006.03615.x","volume":"76","author":"IC Dickinson","year":"2006","unstructured":"Dickinson IC, Whitwell DJ, Battistuta D, et al. Surgical margin and its influence on survival in soft tissue sarcoma. ANZ J Surg. 2006;76:104\u20139.","journal-title":"ANZ J Surg"},{"key":"1410_CR46","doi-asserted-by":"crossref","unstructured":"Liu C-Y, Yen C-C, Chen W-M, et al. Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence. Ann Surg Oncol. 2010;17:2102\u20132111.","DOI":"10.1245\/s10434-010-0997-0"},{"key":"1410_CR47","doi-asserted-by":"crossref","unstructured":"Vraa S, Keller J, Nielsen OS, et al. Soft-tissue sarcoma of the thigh: surgical margin influences local recurrence but not survival in 152 patients. Acta Orthop Scand. 2001;72:72\u201377.","DOI":"10.1080\/000164701753606734"},{"key":"1410_CR48","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1007\/s11999-010-1471-9","volume":"468","author":"EN Novais","year":"2010","unstructured":"Novais EN, Demiralp B, Alderete J, et al. Do surgical margin and local recurrence influence survival in soft tissue sarcomas? Clin Orthop Relat Res. 2010;468:3003\u201311.","journal-title":"Clin Orthop Relat Res"},{"key":"1410_CR49","doi-asserted-by":"publisher","unstructured":"Malik N, Traweek R, Lyu HG, et al. Timing and frequency of surveillance after resection of extremity and trunk soft tissue sarcoma: identifying opportunities for improvement. Annals of surgical oncology. 2026. https:\/\/doi.org\/10.1245\/s10434-026-19337-2.","DOI":"10.1245\/s10434-026-19337-2"},{"key":"1410_CR50","doi-asserted-by":"crossref","unstructured":"Spunt SL, Million L, Chi Y-Y, et al. A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children\u2019s Oncology Group prospective study. Lancet Oncol. 2020;21:145\u2013161.","DOI":"10.1016\/S1470-2045(19)30672-2"},{"key":"1410_CR51","doi-asserted-by":"crossref","unstructured":"Biau DJ, Ferguson PC, Chung P, et al. Local recurrence of localized soft tissue sarcoma. Cancer.\u00a02012;118:5867\u20135877.","DOI":"10.1002\/cncr.27639"},{"key":"1410_CR52","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2147\/CMAR.S159641","volume":"10","author":"NT Hoang","year":"2018","unstructured":"Hoang NT, Acevedo LA, Mann MJ, Tolani B. A review of soft-tissue sarcomas: translation of biological advances into treatment measures. Cancer Manag Res. 2018;10:1089\u2013114.","journal-title":"Cancer Manag Res"},{"key":"1410_CR53","doi-asserted-by":"crossref","unstructured":"Osterloh J, Schmid A, Runkel A, et al. Impact of surgical margins on recurrence after resection of atypical lipomatous tumours: A single-center retrospective analysis. Surgery. 2026;190:109850.","DOI":"10.1016\/j.surg.2025.109850"},{"key":"1410_CR54","doi-asserted-by":"publisher","unstructured":"Callegaro D, Sarre Lazcano C, Cardona K. ASO Practice guidelines series: soft tissue sarcoma of the extremities and superficial trunk. Ann Surg Oncol. 2025. https:\/\/doi.org\/10.1245\/s10434-025-18223-7.","DOI":"10.1245\/s10434-025-18223-7"},{"key":"1410_CR55","doi-asserted-by":"crossref","unstructured":"Hayes AJ, Nixon IF, Strauss DC, et al. UK guidelines for the management of soft tissue sarcomas. Br J Cancer. 2025;132:11\u201331.","DOI":"10.1038\/s41416-024-02674-y"},{"key":"1410_CR56","doi-asserted-by":"crossref","unstructured":"Blay JY, Hindi N, Bollard J, et al. SELNET clinical practice guidelines for soft tissue sarcoma and GIST. Cancer Treat Rev. 2022;102:102312.","DOI":"10.1016\/j.ctrv.2023.102523"},{"key":"1410_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31062","volume":"71","author":"DP Douglass","year":"2024","unstructured":"Douglass DP, Coffin CM, Randall RL, et al. Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: a report from Children\u2019s Oncology Group study ARST0332. Pediatr Blood Cancer. 2024;71:e31062.","journal-title":"Pediatr Blood Cancer"},{"key":"1410_CR58","doi-asserted-by":"crossref","unstructured":"Kobbeltvedt MR, Lobmaier I, Spreafico M, et al. A comparison of the risk prediction models PERSARC and Sarculator in patients with localized soft tissue sarcoma of the extremities and trunk wall. ESMO Open. 2025;10:105517.","DOI":"10.1016\/j.esmoop.2025.105517"},{"key":"1410_CR59","doi-asserted-by":"crossref","unstructured":"Acem I, van Houdt WJ, Gr\u00fcnhagen DJ, et al. The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC. Eur J Cancer. 2022;165:71\u201380.","DOI":"10.1016\/j.ejca.2022.01.013"},{"key":"1410_CR60","doi-asserted-by":"publisher","unstructured":"Callegaro D, Tin\u00e8 G, Oppong FB, et al. CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS). Clinical cancer research : an official journal of the American Association for Cancer Research. 2025;31. https:\/\/doi.org\/10.1158\/1078-0432.CCR-25-0099.","DOI":"10.1158\/1078-0432.CCR-25-0099"},{"key":"1410_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10121-5","author":"F Gouin","year":"2022","unstructured":"Gouin F, Stoeckle E, Honor\u00e9 C, et al. Overall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: a nationwide cohort analysis. BMC Cancer. 2022. https:\/\/doi.org\/10.1186\/s12885-022-10121-5.","journal-title":"BMC Cancer"},{"key":"1410_CR62","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijrobp.2018.05.055","volume":"102","author":"R Boughzala-Bennadji","year":"2018","unstructured":"Boughzala-Bennadji R, Stoeckle E, Le P\u00e9choux C, et al. Localized myxofibrosarcomas: roles of surgical margins and adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2018;102:399\u2013406.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1410_CR63","first-page":"35","volume":"11","author":"Y Steubing","year":"2026","unstructured":"Steubing Y, Wallner C, Lehnhardt M, et al. Interdisciplinary therapy of extremity soft tissue sarcomas: current evidence on systemic treatments and the role of reconstructive surgery. Innov Surg Sci. 2025 ;11:35\u201344.","journal-title":"Innov Surg Sci"},{"key":"1410_CR64","doi-asserted-by":"publisher","unstructured":"Stauss R, Aigner A, Richter A, et al. The prognostic significance of surgical resection margins for local recurrence, distant metastasis, and overall survival in sarcoma. Journal of surgical oncology. 2023;128. https:\/\/doi.org\/10.1002\/jso.27411.","DOI":"10.1002\/jso.27411"},{"key":"1410_CR65","doi-asserted-by":"publisher","unstructured":"Cates MM, Cates JMM. Surgical resection margin classifications for high-grade pleomorphic soft tissue sarcomas of the extremity or trunk: definitions of adequate resection margins and recommendations for sampling margins from primary resection specimens. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2019:32. https:\/\/doi.org\/10.1038\/s41379-019-0278-9.","DOI":"10.1038\/s41379-019-0278-9"},{"key":"1410_CR66","doi-asserted-by":"crossref","unstructured":"Cates VM, Cates JMM. Surgical resection margin classifications for high-grade pleomorphic soft tissue sarcomas of the extremity or trunk after neoadjuvant cytotoxic therapy. Am J Surg Pathol. 2019;43:844\u2013850.","DOI":"10.1097\/PAS.0000000000001246"},{"key":"1410_CR67","doi-asserted-by":"crossref","unstructured":"Hoang MN, Doumanidis P, Nyqvist E, et al. Effect of surgical margins on local recurrence patterns of myxofibrosarcomas: a retrospective cohort study from the stockholm sarcoma centre. J Surg Oncol. 2025;132:1116\u20131121.","DOI":"10.1002\/jso.70076"},{"key":"1410_CR68","doi-asserted-by":"publisher","unstructured":"Yurtbay A, Co\u015fkun HS, Say F, Dabak N. Is the thickness of the margin associated with local recurrence and survival in patients with myxofibrosarcoma? clinical orthopaedics and related research. 2023;481. https:\/\/doi.org\/10.1097\/CORR.0000000000002709.","DOI":"10.1097\/CORR.0000000000002709"},{"key":"1410_CR69","doi-asserted-by":"publisher","unstructured":"Tom\u00e1\u0161 T, Pazourek L, Kub\u00ed\u010dek M, et al. Clear surgical margins as a prognostic indicator for disease recurrence, with no impact on survival rates in patients with myxofibrosarcoma. Scientific reports. 2024;14. https:\/\/doi.org\/10.1038\/s41598-024-63035-6.","DOI":"10.1038\/s41598-024-63035-6"},{"key":"1410_CR70","doi-asserted-by":"publisher","unstructured":"Berner JE, Crowley TP, Teelucksingh S, et al. The importance of clear margins in myxofibrosarcoma: Improving local control by means of staged resection and reconstruction. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2021:47. https:\/\/doi.org\/10.1016\/j.ejso.2021.06.017.","DOI":"10.1016\/j.ejso.2021.06.017"},{"key":"1410_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17223637","author":"L Garayua-Cruz","year":"2025","unstructured":"Garayua-Cruz L, Broida SE, Sullivan MH, et al. Staged reconstruction is not necessary following oncologic resection of superficial myxofibrosarcoma. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17223637.","journal-title":"Cancers (Basel)"},{"key":"1410_CR72","doi-asserted-by":"crossref","unstructured":"Bonvalot S, Gaignard E, Stoeckle E, et al. Survival benefit of the surgical management of retroperitoneal sarcoma in a reference center: a nationwide study of the french sarcoma group from the netsarc database. Ann Surg Oncol. 2019;26:2286\u20132293.","DOI":"10.1245\/s10434-019-07421-9"},{"key":"1410_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/BF02524350","author":"DA Kooby","year":"2004","unstructured":"Kooby DA, Antonescu CR, Brennan MF, Singer S. Atypical lipomatous tumour\/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol. 2004. https:\/\/doi.org\/10.1007\/BF02524350.","journal-title":"Ann Surg Oncol"},{"key":"1410_CR74","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1177\/00031348211054536","volume":"87","author":"CR Olson","year":"2021","unstructured":"Olson CR, Suarez-Kelly LP, Ethun CG, et al. Resection status does not impact recurrence in well-differentiated liposarcoma of the extremity. Am Surg. 2021;87:1752\u20139.","journal-title":"Am Surg"},{"key":"1410_CR75","doi-asserted-by":"publisher","unstructured":"Choi KY, Jost E, Mack L, Bouchard-Fortier A. Surgical management of truncal and extremities atypical lipomatous tumours\/well-differentiated liposarcoma: A systematic review of the literature. American journal of surgery. 2020;219. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.01.046.","DOI":"10.1016\/j.amjsurg.2020.01.046"},{"key":"1410_CR76","doi-asserted-by":"publisher","unstructured":"Segu HV, Rampam S, Gonzalez MR, et al. Comparison of local recurrence rates between wide resection and expanded marginal excision in atypical lipomatous tumours. Annals of surgical oncology. 2025:32.https:\/\/doi.org\/10.1245\/s10434-025-17606-0.","DOI":"10.1245\/s10434-025-17606-0"},{"key":"1410_CR77","doi-asserted-by":"crossref","unstructured":"Bompas E, Campion L, Toulmonde M, et al. Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database. Eur J Cancer. 2025;229:115788.","DOI":"10.1016\/j.ejca.2025.115788"},{"key":"1410_CR78","unstructured":"Cao J, Wang J, He C, Fang M. Angiosarcoma: a review of diagnosis and current treatment. Am J Cancer Res. 2019;9:2303\u20132313."},{"key":"1410_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70263","author":"RE Aubrey","year":"2026","unstructured":"Aubrey RE, Psarianos P, Santiago AT, et al. Outcomes following definitive treatment of malignant peripheral nerve sheath tumour are significantly worse for patients with neurofibromatosis type 1: a Canadian Sarcoma Research and Clinical Collaboration study. Cancer. 2026. https:\/\/doi.org\/10.1002\/cncr.70263.","journal-title":"Cancer"},{"key":"1410_CR80","doi-asserted-by":"publisher","unstructured":"Kose\u0142a-Paterczyk H, Spa\u0142ek M, Borkowska A, et al. Hypofractionated RT in locally advanced myxoid liposarcomas of extremities or trunk wall: results of a single-arm prospective clinical trial. J Clin Med. 2020:9. https:\/\/doi.org\/10.3390\/jcm9082471.","DOI":"10.3390\/jcm9082471"},{"key":"1410_CR81","doi-asserted-by":"crossref","unstructured":"Pasquali S, Pizzamiglio S, Touati N, et al. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. Eur J Cancer. 2019;109:51\u201360.","DOI":"10.1016\/j.ejca.2018.12.009"},{"key":"1410_CR82","doi-asserted-by":"crossref","unstructured":"Le Cesne A, Ouali M, Leahy MG, et al. Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials. Ann Oncol. 2014;25:2425\u20132432.","DOI":"10.1093\/annonc\/mdu460"},{"key":"1410_CR83","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1245\/s10434-020-09445-y","volume":"28","author":"C Nessim","year":"2021","unstructured":"Nessim C, Raut CP, Callegaro D, et al. Postoperative morbidity after resection of recurrent retroperitoneal sarcoma: a report from the Transatlantic Australasian RPS Working Group (TARPSWG). Ann Surg Oncol. 2021;28:2705\u201314.","journal-title":"Ann Surg Oncol"},{"key":"1410_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103280","volume":"84","author":"F Tirotta","year":"2025","unstructured":"Tirotta F, Fiore M, Bonvalot S, et al. Defining benchmark values for outcomes of comprehensive resection of primary retroperitoneal liposarcoma: a retrospective multicenter study. EClinicalMedicine. 2025;84:103280.","journal-title":"EClinicalMedicine"},{"key":"1410_CR85","doi-asserted-by":"crossref","unstructured":"Callegaro D, Raut CP, Ajayi T, et al. Preoperative RT in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results. Ann Surg. 2023;278:127\u2013134.","DOI":"10.1097\/SLA.0000000000005492"},{"key":"1410_CR86","doi-asserted-by":"crossref","unstructured":"Issels RD, Lindner LH, Verweij J, et al. Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial. JAMA Oncol. 2018;4:483\u2013492.","DOI":"10.1001\/jamaoncol.2017.4996"},{"key":"1410_CR87","doi-asserted-by":"crossref","unstructured":"Issels RD, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010;11:561\u2013570.","DOI":"10.1016\/S1470-2045(10)70071-1"},{"key":"1410_CR88","doi-asserted-by":"crossref","unstructured":"Jouppe P-O, Regenet N, Salame E, et al. Retroperitoneal soft tissue sarcomas: Predictive factors for incomplete resection. J Visc Surg. 2024;161:90\u201398.","DOI":"10.1016\/j.jviscsurg.2023.10.002"},{"key":"1410_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102523","volume":"115","author":"JY Blay","year":"2023","unstructured":"Blay JY, Hindi N, Bollard J, et al. Corrigendum to \u2018SELNET clinical practice guidelines for soft tissue sarcoma and GIST\u2019 [Cancer Treat. Rev. 102 (2021) 102312]. Cancer Treat Rev. 2023;115:102523.","journal-title":"Cancer Treat Rev"},{"key":"1410_CR90","doi-asserted-by":"crossref","unstructured":"Crago AM, Cardona K, Kose\u0142a-Paterczyk H, Rutkowski P. Management of myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Surg Oncol Clin N Am. 2022;31:419\u2013430.","DOI":"10.1016\/j.soc.2022.03.006"},{"key":"1410_CR91","doi-asserted-by":"crossref","unstructured":"Decanter G, Stoeckle E, Honore C, et al. Watch and wait approach for re-excision after unplanned yet macroscopically complete excision of extremity and superficial truncal soft tissue sarcoma is safe and does not affect metastatic risk or amputation rate. Ann Surg Oncol. 2019;26:3526\u20133534.","DOI":"10.1245\/s10434-019-07494-6"},{"key":"1410_CR92","doi-asserted-by":"publisher","unstructured":"Spa\u0142ek MJ, Kozak K, Czarnecka AM, et al. Neoadjuvant treatment options in soft tissue sarcomas. Cancers (Basel). 2020:12. https:\/\/doi.org\/10.3390\/cancers12082061.","DOI":"10.3390\/cancers12082061"},{"key":"1410_CR93","doi-asserted-by":"crossref","unstructured":"Sugiura H, Tsukushi S, Yoshida M, Nishida Y. What is the success of repeat surgical treatment of a local recurrence after initial wide resection of soft tissue sarcomas? Clin Orthop Relat Res. 2018;476:1791\u20131800.","DOI":"10.1007\/s11999.0000000000000158"},{"key":"1410_CR94","doi-asserted-by":"publisher","unstructured":"Yurtbay A, Ayd\u0131n \u015eim\u015fek \u015e, Cengiz T, et al. The impact of surgical margin distance on local recurrence and survival in patients with Soft Tissue Sarcoma. Medicina (Kaunas).\u00a02025:61. https:\/\/doi.org\/10.3390\/medicina61020289.","DOI":"10.3390\/medicina61020289"},{"key":"1410_CR95","doi-asserted-by":"publisher","unstructured":"Jubane M, Rennick AC, Villavicencio JJ, et al. Imaging-based disease assessment and management recommendations: impact of multidisciplinary sarcoma tumour board. Cancers (Basel). 2024:16. https:\/\/doi.org\/10.3390\/cancers16152674.","DOI":"10.3390\/cancers16152674"},{"key":"1410_CR96","doi-asserted-by":"publisher","unstructured":"Haussmann J, Matuschek C, B\u00f6lke E, et al. Comparison of different systemic therapeutic regimes in resectable soft-tissue sarcoma-results of a network meta-analysis. Cancers (Basel). 2021:13. https:\/\/doi.org\/10.3390\/cancers13225631.","DOI":"10.3390\/cancers13225631"},{"key":"1410_CR97","doi-asserted-by":"crossref","unstructured":"Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012;13:1045\u20131054.","DOI":"10.1016\/S1470-2045(12)70346-7"},{"key":"1410_CR98","doi-asserted-by":"crossref","unstructured":"Goh MH, Gonzalez MR, Heiling HM, et al. Adjuvant chemotherapy in localized, resectable extremity and truncal soft tissue sarcoma and survival outcomes - A systematic review and meta-analysis of randomized controlled trials. Cancer. 2025:131:e35792.","DOI":"10.1002\/cncr.35792"},{"key":"1410_CR99","doi-asserted-by":"crossref","unstructured":"Gimeno M, San Juli\u00e1n M, Cambeiro M, et al. Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled study. Radiother Oncol. 2019;135:91\u201399.","DOI":"10.1016\/j.radonc.2019.02.011"},{"key":"1410_CR100","doi-asserted-by":"crossref","unstructured":"Montreuil J, Kholodovsky E, Markowitz M, et al. Brachytherapy for soft tissue sarcoma: Maintaining local control while minimizing complications. J Surg Oncol. 2025;131:965\u2013975.","DOI":"10.1002\/jso.27999"},{"key":"1410_CR101","doi-asserted-by":"crossref","unstructured":"Angele MK, Albertsmeier M, Prix NJ, et al. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg. 2014;260:749\u2009\u2212\u200954; discussion 754-6.","DOI":"10.1097\/SLA.0000000000000978"},{"key":"1410_CR102","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2021.09.015","volume":"158","author":"RD Issels","year":"2021","unstructured":"Issels RD, Noessner E, Lindner LH, et al. Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: a translational research program of the EORTC 62961-ESHO 95 randomised clinical trial. Eur J Cancer. 2021;158:123\u201332.","journal-title":"Eur J Cancer"},{"key":"1410_CR103","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.prro.2021.04.005","volume":"11","author":"KE Salerno","year":"2021","unstructured":"Salerno KE, Alektiar KM, Baldini EH, et al. Radiation therapy for treatment of soft tissue sarcoma in adults: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol. 2021;11:339\u201351.","journal-title":"Pract Radiat Oncol"},{"key":"1410_CR104","doi-asserted-by":"publisher","unstructured":"Fujiwara T, Stevenson J, Parry M, et al. What is an adequate margin for infiltrative soft-tissue sarcomas? European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2020:46. https:\/\/doi.org\/10.1016\/j.ejso.2019.10.005.","DOI":"10.1016\/j.ejso.2019.10.005"},{"key":"1410_CR105","doi-asserted-by":"crossref","unstructured":"Fairweather M, Sulciner M, Jolissaint JS, et al. Neoadjuvant RT for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis. EClinicalMedicine. 2026;93:103805.","DOI":"10.1016\/j.eclinm.2026.103805"},{"key":"1410_CR106","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1200\/JCO.1996.14.3.859","volume":"14","author":"PW Pisters","year":"1996","unstructured":"Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14:859\u201368.","journal-title":"J Clin Oncol"},{"key":"1410_CR107","doi-asserted-by":"crossref","unstructured":"Harrison LB, Franzese F, Gaynor JJ, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys. 1993;27:259\u2013265.","DOI":"10.1016\/0360-3016(93)90236-O"},{"key":"1410_CR108","doi-asserted-by":"crossref","unstructured":"Alektiar KM, Brennan MF, Singer S (2011) Local control comparison of adjuvant brachytherapy to intensity-modulated RT in primary high-grade sarcoma of the extremity. Cancer 117:3229\u2013323","DOI":"10.1002\/cncr.25882"},{"key":"1410_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.111136","volume":"212","author":"R Krcek","year":"2025","unstructured":"Krcek R, Griffin AM, Catton CN, et al. Outcomes of local therapies for recurrent and radiation-associated soft tissue sarcomas of the extremities and trunk: is there a role for re-irradiation? Radiother Oncol. 2025;212:111136.","journal-title":"Radiother Oncol"},{"key":"1410_CR110","doi-asserted-by":"crossref","unstructured":"Zasadzi\u0144ski K, Bochy\u0144ska A, Borkowska A, et al. Reirradiation for locally recurrent soft tissue sarcomas: A systematic review. Clin Transl Radiat Oncol. 2025 ;56:101088.","DOI":"10.1016\/j.ctro.2025.101088"},{"key":"1410_CR111","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/cncr.23592","volume":"113","author":"N Pervaiz","year":"2008","unstructured":"Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573\u201381.","journal-title":"Cancer"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-026-01410-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-026-01410-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-026-01410-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:03:24Z","timestamp":1787339004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-026-01410-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1410"],"URL":"https:\/\/doi.org\/10.1007\/s11864-026-01410-3","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"24 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"43"}}